Join the fight
against antimicrobial resistance.

Antibiogo is a free mobile app with one goal: improving care quality for patients at every level of the health system by providing reliable antibiotic susceptibility testing (AST) analyses to labs.

Antibiogo petri dish review screen

Years of research


Research partners


LMIC countries in which
Antibiogo was evaluated


free diagnostics
test with a CE marking

Logo Médecins Sans Frontières

An easy to read diagnostic test, ensuring everyone can join in the fight against AMR.

Antibiogo is a digital health tool that supports lab techs everywhere in delivering qualitative, secure and accurate Antibiotic Susceptibility Testing, to raising the quality of data collected within hospitals which in turn can be used to improve empirical treatments.

Antibiogo also comprehends that in the face of growing Antimicrobial Resistance (AMR), we need a multidisciplinary approach. That is why while our first intended users are lab techs, Antibiogo’s results were made to be understandable and actionable by clinicians and nurses alike.

Our goal is simple: to simplify and streamline the AST process, empowering laboratories to make informed decisions swiftly and accurately.

A CE approved tool

Antibiogo is the first free diagnostics test with a CE marking, meaning it conforms with European health, safety, and environmental protection standards.

Logo Médecins Sans Frontières
Made by The MSF Foundation with the precious support of our partners.

Who made that

We collaborated with experts in the field to bring you this game-changing digital health tool.

About us
Médecins Sans Frontières logo

Médecins Sans Frontières

Médecins Sans Frontières is an international humanitarian organization that has been providing medical aid in conflict zones, natural disasters, and epidemics worldwide for 60+ years.
Fondation Médecins Sans Frontières logo

The MSF Foundation

The MSF Foundation is a branch of Médecins Sans Frontières dedicated to innovation and research to improve the effectiveness of humanitarian medical aid.
i2a logo


i2a Diagnostics develops innovative microbiological diagnostic systems, including automated agar-based antibiogram readers, to improve lab efficiency and patient care.
Laboratoire de Mathématiques et Modélisation d'Évry logo

Laboratoire de Mathématiques et Modélisation d'Évry

LaMME conducts advanced research in mathematical analysis, probabilities, and statistics, applying these to fields such as finance, genomics, and life sciences.
Henri Mondor Hospital logo

Henri Mondor Hospital

The Henri Mondor Hospital is a major teaching hospital offering a wide range of medical services and specializing in advanced surgical and critical care.
UMR logo

UMR Genoscope Metabolic

The UMR Genoscope Metabolic at the Genoscope National Sequencing Center conducts genomic and metabolic research to explore biodiversity and chemical reactions for biotechnological and environmental applications.
Google logo

In 2018, the MSF Foundation won the Google AI impact challenge, which provided the team with a grant and resources from google to work on developing Antibiogo.
EPFL logo


The EPFL is a renowned Swiss university known for its cutting-edge research and education in science, engineering, and technology.
Aga Khan University logo

Aga Khan University Hospital, Nairobi, Kenya

Aga Khan University is renowned for its commitment to excellence in healthcare, education, and research, serving as a beacon of innovation and progress in East Africa.
CHU La Réunion logo

CHU La Réunion

The CHU La Réunion serves as a vital healthcare hub in the Indian Ocean region with a commitment to innovation and community well-being.

Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit

LOMWRU is a collaborative powerhouse driving groundbreaking medical research in Laos, aiming to tackle infectious diseases and improve healthcare outcomes through innovative scientific inquiry and partnershipto work on developing Antibiogo.
Institut Pasteur de Dakar logo

Pasteur Institute, Dakar

The Pasteur Institute in Dakar is a leading research institution at the forefront of combating infectious diseases in Africa.

Want to give it a try?
Contact us to have early access to Antibiogo

Antibiogo will be released to the public at the end 2024, but we are offering early access to medical institutions.

Website intended for healthcare professionals

According to the provisions of the Code de la Santé Publique, this website is exclusively intended for healthcare professionals. Please certify that you are a healthcare professional.

A healthcare professional is any person authorized to prescribe, dispense, or use in vitro diagnostic medical devices in the exercise of their profession.

I certify